Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis.

Journal of clinical apheresis - 1 Jun 2020

Galiano Matthias, Hammersen Johanna, Sauerstein Katja, Blessing Holger, Rümmele Petra, Purbojo Ariawan, Schöber Martin, Moosmann Julia, Raffelsbauer Gunter, Heibges Andreas, Klingel Reinhard

Abstract excerpt

BACKGROUND: Homozygous familial hypercholesterolemia (hoFH) can cause severe atherosclerotic cardiovascular disease (ASCVD) in early infancy. Diagnosis and initiation of effective lipid-lowering therapy (LLT) are recommended as early as possible to prevent ASCVD-related morbidity and mortality. METHODS: The clinical courses of a pair of siblings with an identical hoFH genotype, who exhibited major similarities of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aorta
Share to Aortic Valve

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Component Removal

Share to Echocardiography

Share to Hyperlipoproteinemia Type II

Share to Lipoproteins

Share to Proprotein Convertase 9

Share to Xanthomatosis

Source

Identifiers

PMID: 32163632
DOI: 10.1002/jca.21772

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis.PMID 32163632Read ↗

Homozygous familial hypercholesterolemia: Summarized case reports.Semantic proximity Read ↗

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.Semantic proximity Read ↗

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Semantic proximity Read ↗

Current management of severe homozygous hypercholesterolaemias.Semantic proximity Read ↗

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNSemantic proximity Read ↗

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.Semantic proximity Read ↗

Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.Semantic proximity Read ↗

Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study.Semantic proximity Read ↗

Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.Semantic proximity Read ↗

Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes.Semantic proximity Read ↗

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).Semantic proximity Read ↗

Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.